Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Kedudukan dalam Saham #7451
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Harga Saham
$35.27
Modal Pasaran
$1.56B
Perubahan (1 hari)
-3.40%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Nisbah P/S bagi Avalyn Pharma Inc. Common Stock (AVLN)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Avalyn Pharma Inc. Common Stock, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Avalyn Pharma Inc. Common Stock dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH